Blog Archives - Page 22 of 77 - NFCR

Blog

The Benefits of Juicing: Fact vs Fiction

No matter who you are or where you live, everyone can benefit by following one simple rule: eat more vegetables! This simple yet important rule often has a huge following in the beginning of a new year as many people are resolute to eat healthier and exercise more. In fact,…...

Read more

Cancer Patients and the Flu: What You Need to Know

The COVID-19 pandemic has not replaced the risks posed by the seasonal flu. Learn why the influenza virus is particularly dangerous for cancer patients and how to keep yourself and your loved ones safe.  With so much attention focused on the ongoing COVID-19 pandemic, it can be easy for us…...

Read more

Biosimilar Drugs: Lowering the Cost of Cancer Care?

The National Foundation for Cancer Research (NFCR) answers some of the most frequently asked questions about biosimilar drugs for cancer treatment. Biologic drugs (biologics) are a special class of medications that are made from living organisms, such as proteins.1 Vaccines, hormones, and anti-allergy medications are all examples of biologics.2 These…...

Read more

Stay Strong, Be Positive: Brianne’s Story

Sometimes life gets busy and all you can do is put your head down and focus. That was what the autumn of 2017 looked like for Brianne Jaeger. She was a busy mother of two in her mid-thirties juggling her office manager role and a busy social life. That autumn…...

Read more

2019 Salisbury Award Winners

Johns Hopkins researchers Emily Han-Chung Hsiue, M.D., and Jacqueline Douglass in the Vogelstein/Kinzler Lab at the Sidney Kimmel Comprehensive Cancer Center have been researching MANAbodies, an entirely novel immunotherapeutic approach which could be a significant weapon against cancer and source of hope for patients. MANAbodies are bispecific antibodies that target…...

Read more

NEW Cervical Cancer Screening Guidelines

Buried amongst the pandemic commotion was American Cancer Society’s newest cervical cancer screening guidelines. Cervical cancer affects women of all ages worldwide and is often dubbed ‘the silent killer’ as it presents with no symptoms in the early stages. Luckily there is an effective screening method to help reduce the…...

Read more

10 Ways to Embrace Positivity in 2021

As Americans gathered around to watch the annual ball drop, most people were relieved to finally bid farewell to the unprecedented year of 2020. The year had been exceptionally challenging in every way imaginable – financially, physically, mentally, and emotionally. Though it was truly amazing to see people and organizations…...

Read more

Family Health History: Talk with Your Loved Ones This Holiday Season

From marriage proposals to politics, many topics are discussed around the holiday dinner table. This year, make sure to talk with your loved ones about your family health history to help better understand your unique health risks. The holiday season is approaching. As you get together with loved ones —…...

Read more

Childhood Cancer Treatment by NFCR Partner Receives Fast Track Review and More Good News From the FDA

Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, recently announced that the Unites States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) to volasertib, one of its drugs. Volasertib is a small molecular inhibitor that has been…...

Read more

NFCR-Supported Researcher Leads Study Aiming to Understand Which Patients May Respond Best to Immunotherapy

New approach developed by Dr. Rakesh Jain and his research team identifies biomarkers that may indicate which patients will best respond to immune checkpoint blockade therapies. A research team led by NFCR-supported scientist Rakesh K. Jain, PhD, the Andrew Werk Cook Professor of Tumor Biology at Harvard Medical School and…...

Read more